Riggs Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-4
Closed -$503 – 213
2025
Q2
$503 Buy
+4
New +$498 ﹤0.01% 841
2022
Q2
– Sell
-10
Closed -$2K – 298
2022
Q1
$2K Hold
10
– – ﹤0.01% 289
2021
Q4
$2K Hold
10
– – ﹤0.01% 296
2021
Q3
$3K Hold
10
– – ﹤0.01% 283
2021
Q2
$3K Hold
10
– – ﹤0.01% 280
2021
Q1
$3K Buy
+10
New +$2.7K ﹤0.01% 252

Other funds holding BIIB

Riggs Asset Management's BIIB Position: Q3 2025 in Review

Riggs Asset Management sold out of Biogen (BIIB) in Q3 2025, closing a stake of 4 shares — an estimated $503 sold.

Riggs Asset Management first reported a position in BIIB in Q1 2021 and held it in 6 quarters. The position peaked at $3K in Q3 2021. 907 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Riggs Asset Management reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 4 Biogen shares in Q3 2025, an estimated $503.
  • Riggs Asset Management first reported a position in Biogen in Q1 2021 and held it in 6 quarters.
  • Riggs Asset Management's Biogen position peaked at $3K in Q3 2021.
  • 907 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.